pharmacy bosses say Drug shortages are a “new normal” in the UK and are being exacerbated by Brexit, a report by the Nuffield Trust health thinktank has warned. A dramatic recent spike in the ...
The number of U.S. drug shortages has reached a new all-time high ... The group tracks national drug shortages quarterly, and the most recent update from March found there are 323 active drug ...
The Senate Finance Committee has introduced bipartisan legislation that proposes using Medicaid and Medicare programs to help prevent and reduce generic drug shortages; US indicators for COVID-19, flu ...
pharmacy bosses say Drug shortages are a “new normal” in the UK and are being exacerbated by Brexit, a report by the Nuffield Trust health thinktank has warned. A dramatic recent spike in the ...
Drug shortages have reached record levels, hitting a new peak of 323 medicines in the ... hospital crash carts and procedural areas. Ongoing national shortages of therapies for attention-deficit ...
Ongoing national ... root causes of drug shortages,” Abramowitz said. “It’s long past time to put an end to drug shortages.” A March 2023 report by the Senate Homeland Security Committee ...
the average drug shortage impacted more than half a million consumers, with many being older adults ages 65 to 85, the Department of Health and Human Services shared in a report to Congress last May.
Drug shortages in the UK have more than doubled ... the availability of alternative medicines in the long run. The report underscores how Brexit has intensified vulnerabilities in global and ...
This includes drugs like oxytocin, Rho(D) immune globulin, standard of care chemotherapy, pain and sedation medications, and ADHD medications. The "ongoing national shortages of therapies for ...
Ongoing national shortages ... root causes of drug shortages," Abramowitz said. "ASHP will continue to engage with policymakers regularly as we guide efforts to draft and pass new legislation ...
From 2016 to 2020, the average drug shortage impacted more than half a million consumers, with many being older adults ages 65 to 85, the Department of Health and Human Services shared in a report to ...
It has to do with middlemen who have made manufacturing generic injectable drugs unprofitable, magnifying the risk of shortages ... purchasing,” the report states. None of this really deals with the ...